SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a IBB0979
21 Jul 2023 //
PR NEWSWIRE
SunHo Begins Dosing in PI/II Trial of Two Immunocytokines: IAP0971, IAE0972
07 Jul 2022 //
PRNEWSWIRE
21 Jul 2023 //
PR NEWSWIRE
07 Jul 2022 //
PRNEWSWIRE